Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
INNOventure is a venture capital fund founded by Marcin Bielówka and Marcin Molo, based in Poland. The firm focuses on early-stage investments, primarily in Europe, and aims to support scientists, engineers, and entrepreneurs in developing their projects. Specific details about fund size and assets under management are not disclosed.
INNOventure invests in early-stage companies across sectors such as healthcare, IoT, AI, marketing, insurtech, and biotech. The fund provides seed capital and acts as a first-contact investor, helping founders commercialize their innovative projects and build value based on research and development outcomes.
Notable companies in INNOventure's portfolio include Cardiomatics, which focuses on AI-driven medical diagnostics; DigitalFirst.AI, specializing in AI marketing strategies; and Phonemic, developing IoT solutions. Other portfolio companies include Laven in MedTech, Neuromedical for cognitive disorder treatment, RevDeBug for AI software debugging, and Sky Engine for IT solutions. The firm has also seen exits from a global translation services platform and a telemedicine device.
Submit your pitch through their form at https://innoventure.vc.
INNOventure typically participates as a lead investor in early-stage funding rounds, providing the necessary capital and support to help startups grow.
The firm is open to follow-on investments, especially if the startup demonstrates significant progress and potential for growth after the initial funding.
Specific details about the size of INNOventure's current fund are not publicly available.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.